Gene analysis reveals hidden subtypes of deadly bile duct cancer

Researchers have identified distinct genetic signatures within cholangiocarcinoma, a rare and aggressive bile duct cancer, suggesting the disease is not one but several different conditions. The findings could reshape how oncologists diagnose and treat the disease, potentially unlocking targeted therapies for specific patient groups.

Originaltitel: Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma